Search research articles
Contact Us
Filters
Showing results (141-150 of 191) with videos related to
Page
of 20
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy
T Shinkai, K Eguchi, Y Sasaki, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1994
CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer
N Yamamoto, T Tamura, A Karato, et al.
Japanese Journal of Clinical Oncology
|
October 1, 1991
The frequency and management of infectious episodes and sepsis in small cell lung cancer patients receiving intensive chemotherapy with granulocyte-colony stimulating factor
F Oshita, T Tamura, H Okamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2006
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Y Ohe, Y Ohashi, K Kubota, et al.
Japanese Journal of Clinical Oncology
|
December 1, 1990
Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer
Y Ohe, T Shinkai, K Eguchi, et al.
Japanese Journal of Cancer Research : Gann
|
December 1, 1995
Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions
F Oshita, T Kurata, T Kasai, et al.
Japanese Journal of Clinical Oncology
|
March 1, 1989
Phase II study of carboplatin in non-small cell lung cancer
T Tamura, T Shinkai, K Eguchi, et al.
Journal of Molecular Recognition : JMR
|
June 1, 1988
Glycolipid-directed FH6 monoclonal antibody recognizes high molecular weight glycoprotein antigen carrying sialyl Lex-i determinant in the culture supernatant of PC-9 cells
Y Yamagata, K Shigeta, T Masuda, et al.
Japanese Journal of Clinical Oncology
|
May 5, 2001
Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients
Y Ohe, S Niho, R Kakinuma, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer
M Fukuda, T Shinkai, K Eguchi, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 191) with videos related to
Sort By:
Page
of 20
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy
T Shinkai, K Eguchi, Y Sasaki, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1994
CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer
N Yamamoto, T Tamura, A Karato, et al.
Japanese Journal of Clinical Oncology
|
October 1, 1991
The frequency and management of infectious episodes and sepsis in small cell lung cancer patients receiving intensive chemotherapy with granulocyte-colony stimulating factor
F Oshita, T Tamura, H Okamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2006
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Y Ohe, Y Ohashi, K Kubota, et al.
Japanese Journal of Clinical Oncology
|
December 1, 1990
Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer
Y Ohe, T Shinkai, K Eguchi, et al.
Japanese Journal of Cancer Research : Gann
|
December 1, 1995
Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions
F Oshita, T Kurata, T Kasai, et al.
Japanese Journal of Clinical Oncology
|
March 1, 1989
Phase II study of carboplatin in non-small cell lung cancer
T Tamura, T Shinkai, K Eguchi, et al.
Journal of Molecular Recognition : JMR
|
June 1, 1988
Glycolipid-directed FH6 monoclonal antibody recognizes high molecular weight glycoprotein antigen carrying sialyl Lex-i determinant in the culture supernatant of PC-9 cells
Y Yamagata, K Shigeta, T Masuda, et al.
Japanese Journal of Clinical Oncology
|
May 5, 2001
Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients
Y Ohe, S Niho, R Kakinuma, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer
M Fukuda, T Shinkai, K Eguchi, et al.
Page
of 20